Pages that link to "Q28482357"
Jump to navigation
Jump to search
The following pages link to A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma (Q28482357):
Displaying 9 items.
- Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas (Q28076210) (← links)
- Trabectedin in soft tissue sarcomas (Q28085505) (← links)
- Adhesion to carbon nanotube conductive scaffolds forces action-potential appearance in immature rat spinal neurons (Q28387164) (← links)
- Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis. (Q37701702) (← links)
- RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomas (Q38842538) (← links)
- Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma (Q64066124) (← links)
- Relations between approved platinum drugs and non-coding RNAs in mesothelioma (Q91949964) (← links)
- Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma (Q91949972) (← links)
- Current Approaches for Personalized Therapy of Soft Tissue Sarcomas (Q92131504) (← links)